Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Nov;6(6):1139-46.
doi: 10.1161/CIRCHEARTFAILURE.113.000359. Epub 2013 Oct 15.

Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction

Affiliations
Comparative Study

Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction

Susan M Joseph et al. Circ Heart Fail. 2013 Nov.

Abstract

Background: Despite the growing epidemic of heart failure with preserved ejection fraction (HFpEF), no valid measure of patients' health status (symptoms, function, and quality of life) exists. We evaluated the Kansas City Cardiomyopathy Questionnaire (KCCQ), a validated measure of HF with reduced EF, in patients with HFpEF.

Methods and results: Using a prospective HF registry, we dichotomized patients into HF with reduced EF (EF≤ 40) and HFpEF (EF≥50). The associations between New York Heart Association class, a commonly used criterion standard, and KCCQ Overall Summary and Total Symptom domains were evaluated using Spearman correlations and 2-way ANOVA with differences between patients with HF with reduced EF and HFpEF tested with interaction terms. Predictive validity of the KCCQ Overall Summary scores was assessed with Kaplan-Meier curves for death and all-cause hospitalization. Covariate adjustment was made using Cox proportional hazards models. Internal reliability was assessed with Cronbach's α. Among 849 patients, 200 (24%) had HFpEF. KCCQ summary scores were strongly associated with New York Heart Association class in both patients with HFpEF (r=-0.62; P<0.001) and HF with reduced EF (r=-0.55; P=0.27 for interaction). One-year event-free rates by KCCQ category among patients with HFpEF were 0 to 25=13.8%, 26 to 50=59.1%, 51 to 75=73.8%, and 76 to 100=77.8% (log rank P<0.001), with no significant interaction by EF (P=0.37). The KCCQ domains demonstrated high internal consistency among patients with HFpEF (Cronbach's α=0.96 for overall summary and ≥0.69 in all subdomains).

Conclusions: Among patients with HFpEF, the KCCQ seems to be a valid and reliable measure of health status and offers excellent prognostic ability. Future studies should extend and replicate our findings, including the establishment of its responsiveness to clinical change.

Keywords: health status; heart failure, diastolic; quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
KCCQ Summary Score Association with NYHA Class in HFrEF and HFpEF
Figure 2
Figure 2
Kaplan-Meier Curves for Death or Hospitalization Panel A: Entire study cohort, HFrEF and HFpEF, Panel B: In HFpEF (EF>50%)
Figure 3
Figure 3
Cox Proportional Hazards Model for Death and Hospitalization in HFpEF and HFrEF Reference levels: race = White, KCCQ = 76–100.

Similar articles

Cited by

References

    1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England journal of medicine. 2006;355:251–259. - PubMed
    1. Hogg K, McMurray J. The treatment of heart failure with preserved ejection fraction ("diastolic heart failure") Heart failure reviews. 2006;11:141–146. - PubMed
    1. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. Journal of the American College of Cardiology. 2004;43:317–327. - PubMed
    1. McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: Us fda guidance and emerging methods. Expert review of pharmacoeconomics & outcomes research. 2011;11:163–169. - PMC - PubMed
    1. Speight J, Barendse SM. Fda guidance on patient reported outcomes. Bmj. 2010;340:c2921. - PubMed

Publication types